A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection. 2022

David A Jamison, and S Anand Narayanan, and Nídia S Trovão, and Joseph W Guarnieri, and Michael J Topper, and Pedro M Moraes-Vieira, and Viktorija Zaksas, and Keshav K Singh, and Eve Syrkin Wurtele, and Afshin Beheshti
COVID-19 International Research Team, Medford, MA, USA.

COVID-19, the disease caused by SARS-CoV-2, has claimed approximately 5 million lives and 257 million cases reported globally. This virus and disease have significantly affected people worldwide, whether directly and/or indirectly, with a virulent pathogen that continues to evolve as we race to learn how to prevent, control, or cure COVID-19. The focus of this review is on the SARS-CoV-2 virus' mechanism of infection and its proclivity at adapting and restructuring the intracellular environment to support viral replication. We highlight current knowledge and how scientific communities with expertize in viral, cellular, and clinical biology have contributed to increase our understanding of SARS-CoV-2, and how these findings may help explain the widely varied clinical observations of COVID-19 patients.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

David A Jamison, and S Anand Narayanan, and Nídia S Trovão, and Joseph W Guarnieri, and Michael J Topper, and Pedro M Moraes-Vieira, and Viktorija Zaksas, and Keshav K Singh, and Eve Syrkin Wurtele, and Afshin Beheshti
August 2020, Journal of clinical pharmacology,
David A Jamison, and S Anand Narayanan, and Nídia S Trovão, and Joseph W Guarnieri, and Michael J Topper, and Pedro M Moraes-Vieira, and Viktorija Zaksas, and Keshav K Singh, and Eve Syrkin Wurtele, and Afshin Beheshti
March 2022, Giornale italiano di medicina del lavoro ed ergonomia,
David A Jamison, and S Anand Narayanan, and Nídia S Trovão, and Joseph W Guarnieri, and Michael J Topper, and Pedro M Moraes-Vieira, and Viktorija Zaksas, and Keshav K Singh, and Eve Syrkin Wurtele, and Afshin Beheshti
December 2020, The protein journal,
David A Jamison, and S Anand Narayanan, and Nídia S Trovão, and Joseph W Guarnieri, and Michael J Topper, and Pedro M Moraes-Vieira, and Viktorija Zaksas, and Keshav K Singh, and Eve Syrkin Wurtele, and Afshin Beheshti
January 2020, Gynecologic and obstetric investigation,
David A Jamison, and S Anand Narayanan, and Nídia S Trovão, and Joseph W Guarnieri, and Michael J Topper, and Pedro M Moraes-Vieira, and Viktorija Zaksas, and Keshav K Singh, and Eve Syrkin Wurtele, and Afshin Beheshti
November 2021, World journal of virology,
David A Jamison, and S Anand Narayanan, and Nídia S Trovão, and Joseph W Guarnieri, and Michael J Topper, and Pedro M Moraes-Vieira, and Viktorija Zaksas, and Keshav K Singh, and Eve Syrkin Wurtele, and Afshin Beheshti
October 2022, Journal of periodontal research,
David A Jamison, and S Anand Narayanan, and Nídia S Trovão, and Joseph W Guarnieri, and Michael J Topper, and Pedro M Moraes-Vieira, and Viktorija Zaksas, and Keshav K Singh, and Eve Syrkin Wurtele, and Afshin Beheshti
August 2020, Mayo Clinic proceedings,
David A Jamison, and S Anand Narayanan, and Nídia S Trovão, and Joseph W Guarnieri, and Michael J Topper, and Pedro M Moraes-Vieira, and Viktorija Zaksas, and Keshav K Singh, and Eve Syrkin Wurtele, and Afshin Beheshti
July 2022, Journal of personalized medicine,
David A Jamison, and S Anand Narayanan, and Nídia S Trovão, and Joseph W Guarnieri, and Michael J Topper, and Pedro M Moraes-Vieira, and Viktorija Zaksas, and Keshav K Singh, and Eve Syrkin Wurtele, and Afshin Beheshti
January 2022, International journal of preventive medicine,
David A Jamison, and S Anand Narayanan, and Nídia S Trovão, and Joseph W Guarnieri, and Michael J Topper, and Pedro M Moraes-Vieira, and Viktorija Zaksas, and Keshav K Singh, and Eve Syrkin Wurtele, and Afshin Beheshti
January 2022, British journal of biomedical science,
Copied contents to your clipboard!